{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T22:44:54Z","timestamp":1791931494439,"version":"4.3.4"},"reference-count":91,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T00:00:00Z","timestamp":1787616000000},"content-version":"vor","delay-in-days":236,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","cmghjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cellular and Molecular Gastroenterology and Hepatology"],"published-print":{"date-parts":[[2026]]},"DOI":"10.1016\/j.jcmgh.2026.101867","type":"journal-article","created":{"date-parts":[[2026,8,31]],"date-time":"2026-08-31T06:01:40Z","timestamp":1788156100000},"page":"101867","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Mapping the Impact of Janus Kinase Inhibitors at a Cellular Resolution in Inflammatory Bowel Disease"],"prefix":"10.1016","volume":"20","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8669-2583","authenticated-orcid":false,"given":"Jonas","family":"Louwers","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Evelien","family":"Floor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Femke","family":"van Wijk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yvonne","family":"Vercoulen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3962-6831","authenticated-orcid":false,"given":"Bas","family":"Oldenburg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jcmgh.2026.101867_bib1","doi-asserted-by":"crossref","first-page":"3857","DOI":"10.1016\/j.cell.2022.09.023","article-title":"The JAK-STAT pathway at 30: Much learned, much more to do","volume":"185","author":"Philips","year":"2022","journal-title":"Cell"},{"key":"10.1016\/j.jcmgh.2026.101867_bib2","doi-asserted-by":"crossref","first-page":"1723","DOI":"10.1056\/NEJMoa1606910","article-title":"Tofacitinib as induction and maintenance therapy for ulcerative colitis","volume":"376","author":"Sandborn","year":"2017","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jcmgh.2026.101867_bib3","doi-asserted-by":"crossref","first-page":"2113","DOI":"10.1016\/S0140-6736(22)00581-5","article-title":"Upadacitinib as induction and maintenance therapy for moderately to severely active ulcerative colitis: results from three phase 3, multicentre, double-blind, randomised trials","volume":"399","author":"Danese","year":"2022","journal-title":"Lancet"},{"key":"10.1016\/j.jcmgh.2026.101867_bib4","doi-asserted-by":"crossref","first-page":"2372","DOI":"10.1016\/S0140-6736(21)00666-8","article-title":"Filgotinib as induction and maintenance therapy for ulcerative colitis (SELECTION): a phase 2b\/3 double-blind, randomised, placebo-controlled trial","volume":"397","author":"Feagan","year":"2021","journal-title":"Lancet"},{"key":"10.1016\/j.jcmgh.2026.101867_bib5","doi-asserted-by":"crossref","first-page":"1966","DOI":"10.1056\/NEJMoa2212728","article-title":"Upadacitinib induction and maintenance therapy for Crohn\u2019s disease","volume":"388","author":"Loftus","year":"2023","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jcmgh.2026.101867_bib6","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.1016\/j.cgh.2014.01.029","article-title":"A phase 2 study of tofacitinib, an oral janus kinase inhibitor, in patients with Crohn\u2019s disease","volume":"12","author":"Sandborn","year":"2014","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.jcmgh.2026.101867_bib7","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/S2468-1253(24)00272-3","article-title":"Efficacy and safety of filgotinib as induction and maintenance therapy for Crohn\u2019s disease (DIVERSITY): a phase 3, double-blind, randomised, placebo-controlled trial","volume":"10","author":"Vermeire","year":"2025","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"10.1016\/j.jcmgh.2026.101867_bib8","doi-asserted-by":"crossref","first-page":"1992","DOI":"10.1097\/MIB.0000000000000824","article-title":"Role of monocytes and intestinal macrophages in Crohn\u02bcs disease and ulcerative colitis","volume":"22","author":"Gren","year":"2016","journal-title":"Inflamm Bowel Dis"},{"key":"10.1016\/j.jcmgh.2026.101867_bib9","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1016\/j.immuni.2013.04.004","article-title":"Tissue-resident macrophages self-maintain locally throughout adult life with minimal contribution from circulating monocytes","volume":"38","author":"Hashimoto","year":"2013","journal-title":"Immunity"},{"key":"10.1016\/j.jcmgh.2026.101867_bib10","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1093\/ibd\/izz213","article-title":"Tofacitinib reprograms human monocytes of IBD patients and healthy controls toward a more regulatory phenotype","volume":"26","author":"Cordes","year":"2020","journal-title":"Inflamm Bowel Dis"},{"key":"10.1016\/j.jcmgh.2026.101867_bib11","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1093\/ibd\/izaa280","article-title":"Impaired IFN-\u03b3-dependent STAT3 activation is associated with dysregulation of regulatory and inflammatory signaling in monocytes of ulcerative colitis patients","volume":"27","author":"Cordes","year":"2021","journal-title":"Inflamm Bowel Dis"},{"key":"10.1016\/j.jcmgh.2026.101867_bib12","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1016\/j.mucimm.2025.06.010","article-title":"Tofacitinib ameliorates campylobacter-induced intestinal pathology by suppressing IFN\u03b3 producing ILCs and T cells","volume":"18","author":"Korchagina","year":"2025","journal-title":"Mucosal Immunol"},{"key":"10.1016\/j.jcmgh.2026.101867_bib13","doi-asserted-by":"crossref","DOI":"10.1016\/j.jtauto.2025.100271","article-title":"Tofacitinib downregulates JAK1 and JAK3 on human intestinal monocytes and macrophages without affecting dendritic cells phenotype or function","volume":"10","author":"Arribas-Rodr\u00edguez","year":"2025","journal-title":"J Transl Autoimmun"},{"key":"10.1016\/j.jcmgh.2026.101867_bib14","doi-asserted-by":"crossref","first-page":"1999","DOI":"10.1093\/ibd\/izab116","article-title":"Randomized controlled trial substudy of cell-specific mechanisms of janus kinase 1 inhibition with upadacitinib in the Crohn\u2019s disease intestinal mucosa: analysis from the CELEST study","volume":"27","author":"Aguilar","year":"2021","journal-title":"Inflamm Bowel Dis"},{"key":"10.1016\/j.jcmgh.2026.101867_bib15","doi-asserted-by":"crossref","first-page":"1454","DOI":"10.1038\/s41385-018-0051-2","article-title":"The JAK inhibitor ruxolitinib reduces inflammation in an ILC3-independent model of innate immune colitis","volume":"11","author":"Overstreet","year":"2018","journal-title":"Mucosal Immunol"},{"key":"10.1016\/j.jcmgh.2026.101867_bib16","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1159\/000051908","article-title":"Increased secretion of granulocyte-macrophage colony-stimulating factor in mucosal lesions of inflammatory bowel disease","volume":"63","author":"Noguchi","year":"2001","journal-title":"Digestion"},{"key":"10.1016\/j.jcmgh.2026.101867_bib17","doi-asserted-by":"crossref","first-page":"1997","DOI":"10.1002\/eji.201545802","article-title":"Activation-dependent cell death of human monocytes is a novel mechanism of fine-tuning inflammation and autoimmunity","volume":"46","author":"D\u00e4britz","year":"2016","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.jcmgh.2026.101867_bib18","doi-asserted-by":"crossref","first-page":"3695","DOI":"10.4049\/jimmunol.1600845","article-title":"JAK2 disease-risk variants are gain of function and JAK signaling threshold determines innate receptor-induced proinflammatory cytokine secretion in macrophages","volume":"197","author":"Hedl","year":"2016","journal-title":"J Immunol"},{"key":"10.1016\/j.jcmgh.2026.101867_bib19","doi-asserted-by":"crossref","DOI":"10.1093\/ecco-jcc\/jjaf076","article-title":"Differential effects of tofacitinib on macrophage activation contribute to lack of response in ulcerative colitis patients","volume":"19","author":"Mel\u00f3n-Ardanaz","year":"2025","journal-title":"J Crohns Colitis"},{"key":"10.1016\/j.jcmgh.2026.101867_bib20","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/j.jcmgh.2021.09.004","article-title":"Tofacitinib-induced modulation of intestinal adaptive and innate immunity and factors driving cellular and systemic pharmacokinetics","volume":"13","author":"Texler","year":"2022","journal-title":"Cell Mol Gastroenterol Hepatol"},{"key":"10.1016\/j.jcmgh.2026.101867_bib21","doi-asserted-by":"crossref","DOI":"10.1016\/j.fct.2020.111835","article-title":"Gallic and butyric acids modulated NLRP3 inflammasome markers in a co-culture model of intestinal inflammation","volume":"146","author":"Luzardo-Ocampo","year":"2020","journal-title":"Food Chem Toxicol"},{"key":"10.1016\/j.jcmgh.2026.101867_bib22","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1093\/ecco-jcc\/jjae031","article-title":"Histological outcomes and JAK-STAT signalling in ulcerative colitis patients treated with tofacitinib","volume":"18","author":"van Gennep","year":"2024","journal-title":"J Crohns Colitis"},{"key":"10.1016\/j.jcmgh.2026.101867_bib23","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1093\/ibd\/izy364","article-title":"A JAK1 selective kinase inhibitor and tofacitinib affect macrophage activation and function","volume":"25","author":"De Vries","year":"2019","journal-title":"Inflamm Bowel Dis"},{"key":"10.1016\/j.jcmgh.2026.101867_bib24","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1038\/s41586-024-07501-1","article-title":"A disease-associated gene desert directs macrophage inflammation through ETS2","volume":"630","author":"Stankey","year":"2024","journal-title":"Nature"},{"key":"10.1016\/j.jcmgh.2026.101867_bib25","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-021-98611-7","article-title":"The mannose receptor (CD206) identifies a population of colonic macrophages in health and inflammatory bowel disease","volume":"11","author":"Wright","year":"2021","journal-title":"Sci Rep"},{"key":"10.1016\/j.jcmgh.2026.101867_bib26","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/j.molmed.2013.03.005","article-title":"CD39 and CD73 in immunity and inflammation","volume":"19","author":"Antonioli","year":"2013","journal-title":"Trends Mol Med"},{"key":"10.1016\/j.jcmgh.2026.101867_bib27","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2024.1437512","article-title":"Nonclinical evaluations of deucravacitinib and Janus kinase inhibitors in homeostatic and inflammatory pathways","volume":"15","author":"Johnson","year":"2024","journal-title":"Front Immunol"},{"key":"10.1016\/j.jcmgh.2026.101867_bib28","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1093\/ibd\/izad290","article-title":"Tofacitinib affects M1-like and M2-like polarization and tissue factor expression in macrophages of healthy donors and IBD patients","volume":"30","author":"Lethen","year":"2024","journal-title":"Inflamm Bowel Dis"},{"key":"10.1016\/j.jcmgh.2026.101867_bib29","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0062761","article-title":"Peripheral monocyte functions and activation in patients with quiescent Crohn\u2019s disease","volume":"8","author":"Schwarzmaier","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.jcmgh.2026.101867_bib30","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejps.2025.107365","article-title":"Assessing the effects of tofacitinib on the gut microbiome in inflammatory bowel disease","volume":"216","author":"Favaron","year":"2026","journal-title":"Eur J Pharm Sci"},{"key":"10.1016\/j.jcmgh.2026.101867_bib31","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1016\/j.gastha.2022.01.005","article-title":"Lamina propria phagocyte profiling reveals targetable signaling pathways in refractory inflammatory bowel disease","volume":"1","author":"Jacobsen","year":"2022","journal-title":"Gastro Hep Adv"},{"key":"10.1016\/j.jcmgh.2026.101867_bib32","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1093\/ibd\/izac246","article-title":"The clinical response of upadacitinib and risankizumab is associated with reduced inflammatory bowel disease anti-TNF-\u03b1 inadequate response mechanisms","volume":"29","author":"Wang","year":"2023","journal-title":"Inflamm Bowel Dis"},{"key":"10.1016\/j.jcmgh.2026.101867_bib33","doi-asserted-by":"crossref","first-page":"G396","DOI":"10.1152\/ajpgi.00383.2020","article-title":"Tofacitinib inhibits inflammatory cytokines from ulcerative colitis and healthy mucosal explants and is associated with pSTAT1\/3 reduction in T-cells","volume":"320","author":"Brand","year":"2021","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"10.1016\/j.jcmgh.2026.101867_bib34","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1038\/s41590-019-0415-0","article-title":"Targeting immune cell circuits and trafficking in inflammatory bowel disease","volume":"20","author":"Neurath","year":"2019","journal-title":"Nat Immunol"},{"key":"10.1016\/j.jcmgh.2026.101867_bib35","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1016\/j.immuni.2016.07.007","article-title":"A high-dimensional atlas of human T cell diversity reveals tissue-specific trafficking and cytokine signatures","volume":"45","author":"Wong","year":"2016","journal-title":"Immunity"},{"key":"10.1016\/j.jcmgh.2026.101867_bib36","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1016\/j.cell.2014.10.026","article-title":"Spatial map of human T cell compartmentalization and maintenance over decades of life","volume":"159","author":"Thome","year":"2014","journal-title":"Cell"},{"key":"10.1016\/j.jcmgh.2026.101867_bib37","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1093\/ecco-jcc\/jjaa162","article-title":"The JAK1\/3 inhibitor to tofacitinib suppresses T cell homing and activation in chronic intestinal inflammation","volume":"15","author":"Gerlach","year":"2021","journal-title":"J Crohns Colitis"},{"key":"10.1016\/j.jcmgh.2026.101867_bib38","doi-asserted-by":"crossref","DOI":"10.1093\/ecco-jcc\/jjae117","article-title":"Discordant effects of Janus kinase inhibition ex vivo on inflammatory responses in colonic compared to Ileal Mucosa","volume":"19","author":"Kaboub","year":"2025","journal-title":"J Crohns Colitis"},{"key":"10.1016\/j.jcmgh.2026.101867_bib39","article-title":"TYK2 inhibition enhances Treg differentiation and function while preventing Th1 and Th17 differentiation","volume":"6","author":"Tuomela","year":"2025","journal-title":"Cell Rep Med"},{"key":"10.1016\/j.jcmgh.2026.101867_bib40","doi-asserted-by":"crossref","first-page":"2245","DOI":"10.4049\/jimmunol.2100220","article-title":"Regulation and role of \u03b1E integrin and gut homing integrins in migration and retention of intestinal lymphocytes during inflammatory bowel disease","volume":"207","author":"Keir","year":"2021","journal-title":"J Immunol"},{"key":"10.1016\/j.jcmgh.2026.101867_bib41","doi-asserted-by":"crossref","first-page":"6112","DOI":"10.1038\/s41598-025-87076-7","article-title":"Activated type 17 helper T cells affect tofacitinib treatment outcomes","volume":"15","author":"Ito","year":"2025","journal-title":"Sci Rep"},{"key":"10.1016\/j.jcmgh.2026.101867_bib42","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fimmu.2023.1179311","article-title":"Delayed and limited administration of the JAKinib tofacitinib mitigates chronic DSS-induced colitis","volume":"14","author":"Seal","year":"2023","journal-title":"Front Immunol"},{"key":"10.1016\/j.jcmgh.2026.101867_bib43","article-title":"Deucravacitinib in patients with inflammatory bowel disease: 12-week efficacy and safety results from 3 randomized phase 2 studies in Crohn\u2019s disease and ulcerative colitis","volume":"19","author":"D\u2019Haens","year":"2025","journal-title":"J Crohns Colitis"},{"key":"10.1016\/j.jcmgh.2026.101867_bib44","doi-asserted-by":"crossref","first-page":"15064","DOI":"10.1073\/pnas.0803124105","article-title":"The inner of the two Muc2 mucin-dependent mucus layers in colon is devoid of bacteria","volume":"105","author":"Johansson","year":"2008","journal-title":"Proc Nat Acad Sci U S A"},{"key":"10.1016\/j.jcmgh.2026.101867_bib45","doi-asserted-by":"crossref","first-page":"G495","DOI":"10.1152\/ajpgi.1999.277.3.G495","article-title":"Innate mechanisms of mucosal defense and repair: the best offense is a good defense","volume":"277","author":"Podolsky","year":"1999","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"10.1016\/j.jcmgh.2026.101867_bib46","doi-asserted-by":"crossref","first-page":"883","DOI":"10.7326\/0003-4819-105-6-883","article-title":"Increased intestinal permeability in patients with Crohn\u2019s disease and their relatives. A possible etiologic factor","volume":"105","author":"Hollander","year":"1986","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.jcmgh.2026.101867_bib47","doi-asserted-by":"crossref","first-page":"1322","DOI":"10.1002\/ibd.21211","article-title":"Effects of T cell-induced colonic inflammation on epithelial barrier function","volume":"16","author":"Suenaert","year":"2010","journal-title":"Inflamm Bowel Dis"},{"key":"10.1016\/j.jcmgh.2026.101867_bib48","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.0050054","article-title":"Aberrant mucin assembly in mice causes endoplasmic reticulum stress and spontaneous inflammation resembling ulcerative colitis","volume":"5","author":"Heazlewood","year":"2008","journal-title":"PLoS Med"},{"key":"10.1016\/j.jcmgh.2026.101867_bib49","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1093\/ibd\/izz266","article-title":"The JAK-inhibitor tofacitinib rescues human intestinal epithelial cells and Colonoids from cytokine-induced barrier dysfunction","volume":"26","author":"Sayoc-Becerra","year":"2020","journal-title":"Inflamm Bowel Dis"},{"key":"10.1016\/j.jcmgh.2026.101867_bib50","doi-asserted-by":"crossref","first-page":"3145","DOI":"10.3390\/ijms21093145","article-title":"Potent inhibitory effect of BJ-3105, a 6-Alkoxypyridin-3-ol derivative, on murine colitis is mediated by activating AMPK and inhibiting NOX","volume":"21","author":"Gurung","year":"2020","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.jcmgh.2026.101867_bib51","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1093\/ecco-jcc\/jjaa182","article-title":"The JAK inhibitor tofacitinib rescues intestinal barrier defects caused by disrupted epithelial-macrophage interactions","volume":"15","author":"Spalinger","year":"2021","journal-title":"J Crohns Colitis"},{"key":"10.1016\/j.jcmgh.2026.101867_bib52","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.diff.2008.09.008","article-title":"Differences in goblet cell differentiation between Crohn\u2019s disease and ulcerative colitis","volume":"77","author":"Gersemann","year":"2009","journal-title":"Differentiation"},{"key":"10.1016\/j.jcmgh.2026.101867_bib53","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2022.998373","article-title":"Adherens junction proteins on the move\u2014From the membrane to the nucleus in intestinal diseases","volume":"10","author":"Lessey","year":"2022","journal-title":"Front Cell Dev Biol"},{"key":"10.1016\/j.jcmgh.2026.101867_bib54","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1016\/j.gastro.2005.05.002","article-title":"Interleukin-13 is the key effector Th2 cytokine in ulcerative colitis that affects epithelial tight junctions, apoptosis, and cell restitution","volume":"129","author":"Heller","year":"2005","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jcmgh.2026.101867_bib55","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1136\/gut.2006.094375","article-title":"Changes in expression and distribution of claudin 2, 5 and 8 lead to discontinuous tight junctions and barrier dysfunction in active Crohn\u2019s disease","volume":"56","author":"Zeissig","year":"2007","journal-title":"Gut"},{"key":"10.1016\/j.jcmgh.2026.101867_bib56","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1093\/ibd\/izad007","article-title":"Ruxolitinib alleviates inflammation, apoptosis, and intestinal barrier leakage in ulcerative colitis via STAT3","volume":"29","author":"Li","year":"2023","journal-title":"Inflamm Bowel Dis"},{"key":"10.1016\/j.jcmgh.2026.101867_bib57","doi-asserted-by":"crossref","first-page":"G439","DOI":"10.1152\/ajpgi.00104.2022","article-title":"DNA sensor-associated type I interferon signaling is increased in ulcerative colitis and induces JAK-dependent inflammatory cell death in colonic organoids","volume":"323","author":"Flood","year":"2022","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"10.1016\/j.jcmgh.2026.101867_bib58","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.909896","article-title":"Type-2 cytokines promote the secretion of the eosinophil\u2013attractant CCL26 by intestinal epithelial cells in food-sensitized patients","volume":"13","author":"Vaccaro","year":"2022","journal-title":"Front Immunol"},{"key":"10.1016\/j.jcmgh.2026.101867_bib59","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.1053\/j.gastro.2019.07.031","article-title":"Interferon lambda promotes Paneth cell death via STAT1 signaling in mice and is increased in inflamed Ileal tissues of patients with Crohn\u2019s disease","volume":"157","author":"G\u00fcnther","year":"2019","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jcmgh.2026.101867_bib60","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.882277","article-title":"Tofacitinib downregulates TNF and Poly(I:C)-dependent MHC-II expression in the colonic epithelium","volume":"13","author":"Gopalakrishnan","year":"2022","journal-title":"Front Immunol"},{"key":"10.1016\/j.jcmgh.2026.101867_bib61","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1093\/ibd\/izac212","article-title":"Molecular and functional characterization of human intestinal organoids and monolayers for modeling epithelial barrier","volume":"29","author":"Jelinsky","year":"2023","journal-title":"Inflamm Bowel Dis"},{"key":"10.1016\/j.jcmgh.2026.101867_bib62","doi-asserted-by":"crossref","first-page":"G689","DOI":"10.1152\/ajpgi.00064.2020","article-title":"Interleukin-28A induces epithelial barrier dysfunction in CD patient-derived intestinal organoids","volume":"320","author":"Xu","year":"2021","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"10.1016\/j.jcmgh.2026.101867_bib63","doi-asserted-by":"crossref","first-page":"766","DOI":"10.5009\/gnl220159","article-title":"Novel histone deacetylase 6 inhibitor confers anti-inflammatory effects and enhances gut barrier function","volume":"17","author":"Lee","year":"2023","journal-title":"Gut Liver"},{"key":"10.1016\/j.jcmgh.2026.101867_bib64","article-title":"High-throughput human gut immune co-culture model for evaluating inflammatory bowel disease anti-inflammatory therapies","author":"Peddibhotla","year":"2025","journal-title":"bioRxiv"},{"key":"10.1016\/j.jcmgh.2026.101867_bib65","doi-asserted-by":"crossref","first-page":"152","DOI":"10.3892\/etm.2024.12440","article-title":"Effect of tofacitinib on the phenotype and activity of Caco-2 cells in a model of inflammatory bowel disease","volume":"27","author":"Skudrzyk","year":"2024","journal-title":"Exp Ther Med"},{"key":"10.1016\/j.jcmgh.2026.101867_bib66","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1111\/nyas.13439","article-title":"T cell protein tyrosine phosphatase prevents STAT1 induction of claudin-2 expression in intestinal epithelial cells","volume":"1405","author":"Krishnan","year":"2017","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.jcmgh.2026.101867_bib67","doi-asserted-by":"crossref","DOI":"10.1016\/j.isci.2024.111049","article-title":"Establishment of an ulcerative colitis model using colon organoids derived from human induced pluripotent stem cells","volume":"27","author":"Yokoi","year":"2024","journal-title":"iScience"},{"key":"10.1016\/j.jcmgh.2026.101867_bib68","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1016\/j.stem.2010.11.016","article-title":"Tissue-resident adult stem cell populations of rapidly self-renewing organs","volume":"7","author":"Barker","year":"2010","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.jcmgh.2026.101867_bib69","doi-asserted-by":"crossref","first-page":"224","DOI":"10.3390\/cells10020224","article-title":"JAK-STAT pathway inhibition partially restores intestinal homeostasis in Hdac1- and Hdac2-intestinal epithelial cell-deficient mice","volume":"10","author":"Gonneaud","year":"2021","journal-title":"Cells"},{"key":"10.1016\/j.jcmgh.2026.101867_bib70","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.stemcr.2017.11.015","article-title":"JAK\/STAT-1 signaling is required for reserve intestinal stem cell activation during intestinal regeneration following acute inflammation","volume":"10","author":"Richmond","year":"2018","journal-title":"Stem Cell Rep"},{"key":"10.1016\/j.jcmgh.2026.101867_bib71","doi-asserted-by":"crossref","first-page":"3753","DOI":"10.1038\/s41598-025-86314-2","article-title":"Tofacitinib and budesonide treatment affect stemness and chemokine release in IBD patient-derived colonoids","volume":"15","author":"Sridhar","year":"2025","journal-title":"Sci Rep"},{"key":"10.1016\/j.jcmgh.2026.101867_bib72","article-title":"IFN-\u03b3-Induced intestinal epithelial cell-type-specific programmed cell death: PANoptosis and its modulation in Crohn\u2019s disease","volume":"16","author":"Lee","year":"2025","journal-title":"Front Immunol"},{"key":"10.1016\/j.jcmgh.2026.101867_bib73","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1038\/s41419-021-04151-3","article-title":"TNF-\u03b1 synergises with IFN-\u03b3 to induce caspase-8-JAK1\/2-STAT1-dependent death of intestinal epithelial cells","volume":"12","author":"Woznicki","year":"2021","journal-title":"Cell Death Dis"},{"key":"10.1016\/j.jcmgh.2026.101867_bib74","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1136\/gut.38.2.216","article-title":"Increased interleukin 8 expression in the colon mucosa of patients with inflammatory bowel disease","volume":"38","author":"Daig","year":"1996","journal-title":"Gut"},{"key":"10.1016\/j.jcmgh.2026.101867_bib75","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.655960","article-title":"Regulation of CEACAM family members by IBD-associated triggers in intestinal epithelial cells, their correlation to inflammation and relevance to IBD pathogenesis","volume":"12","author":"Saiz-Gonzalo","year":"2021","journal-title":"Front Immunol"},{"key":"10.1016\/j.jcmgh.2026.101867_bib76","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1002\/art.43210","article-title":"Paradoxical activation of entheseal myeloid cells by JAK1 and Tyk2 inhibitors via interleukin-10 antagonism","volume":"77","author":"Giryes","year":"2025","journal-title":"Arthritis Rheumatol"},{"key":"10.1016\/j.jcmgh.2026.101867_bib79","doi-asserted-by":"crossref","DOI":"10.1093\/ecco-jcc\/jjaf063","article-title":"Drug tissue concentration and STAT3 modulation as determinants of tofacitinib response in ulcerative colitis","volume":"19","author":"Verstockt","year":"2025","journal-title":"J Crohns Colitis"},{"key":"10.1016\/j.jcmgh.2026.101867_bib80","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1053\/j.gastro.2024.07.035","article-title":"Tofacitinib uptake by patient-derived intestinal organoids predicts individual clinical responsiveness","volume":"167","author":"Jang","year":"2024","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jcmgh.2026.101867_bib81","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1111\/cts.13152","article-title":"Evaluation of the potential drug interactions mediated through P-gp, OCT2, and MATE1\/2K with filgotinib in healthy subjects","volume":"15","author":"Hsueh","year":"2022","journal-title":"Clin Transl Sci"},{"key":"10.1016\/j.jcmgh.2026.101867_bib82","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/S0016-5085(00)70210-1","article-title":"High multidrug resistance (P-glycoprotein 170) expression in inflammatory bowel disease patients who fail medical therapy","volume":"118","author":"Farrell","year":"2000","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jcmgh.2026.101867_bib83","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1084\/jem.20130301","article-title":"Pro-inflammatory human Th17 cells selectively express P-glycoprotein and are refractory to glucocorticoids","volume":"211","author":"Ramesh","year":"2014","journal-title":"J Exp Med"},{"key":"10.1016\/j.jcmgh.2026.101867_bib84","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1038\/tpj.2011.16","article-title":"An update on ABCB1 pharmacogenetics: insights from a 3D model into the location and evolutionary conservation of residues corresponding to SNPs associated with drug pharmacokinetics","volume":"11","author":"Wolf","year":"2011","journal-title":"Pharmacogenomics J"},{"key":"10.1016\/j.jcmgh.2026.101867_bib85","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1053\/gast.2003.50010","article-title":"Association between the C3435T MDR1 gene polymorphism and susceptibility for ulcerative colitis","volume":"124","author":"Schwab","year":"2003","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jcmgh.2026.101867_bib86","doi-asserted-by":"crossref","first-page":"3473","DOI":"10.1073\/pnas.97.7.3473","article-title":"Functional polymorphisms of the human multidrug-resistance gene: Multiple sequence variations and correlation of one allele with P-glycoprotein expression and activity in vivo","volume":"97","author":"Hoffmeyer","year":"2000","journal-title":"Proc Nat Acad Sci U S A"},{"key":"10.1016\/j.jcmgh.2026.101867_bib87","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1093\/ecco-jcc\/jjaf087","article-title":"Therapeutic potential of Janus kinase inhibitors for the management of fibrosis in inflammatory bowel disease","volume":"19","author":"Su","year":"2025","journal-title":"J Crohns Colitis"},{"key":"10.1016\/j.jcmgh.2026.101867_bib88","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1038\/s41586-025-09744-y","article-title":"Spatial fibroblast niches define Crohn\u2019s fistulae","volume":"649","author":"McGregor","year":"2026","journal-title":"Nature"},{"key":"10.1016\/j.jcmgh.2026.101867_bib89","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1016\/j.cgh.2024.08.032","article-title":"Efficacy and safety of upadacitinib for perianal fistulizing Crohn\u2019s disease: a post hoc analysis of 3 phase 3 trials","volume":"23","author":"Colombel","year":"2025","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.jcmgh.2026.101867_bib90","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1016\/j.cgh.2025.07.009","article-title":"Efficacy of advanced therapies in achieving remission by disease location in Crohn\u2019s disease: a systematic review and meta-analysis","volume":"24","author":"Lee","year":"2026","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.jcmgh.2026.101867_bib91","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1093\/rheumatology\/kead448","article-title":"Differential properties of Janus kinase inhibitors in the treatment of immune-mediated inflammatory diseases","volume":"63","author":"Taylor","year":"2024","journal-title":"Rheumatology"},{"key":"10.1016\/j.jcmgh.2026.101867_bib92","doi-asserted-by":"crossref","first-page":"5808","DOI":"10.1038\/s41467-026-72482-w","article-title":"Spatial transcriptomics atlas of inflammatory bowel disease to guide implementation in research consortiums and clinical trials","volume":"17","author":"Li","year":"2026","journal-title":"Nat Commun"},{"key":"10.1016\/j.jcmgh.2026.101867_bib93","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1038\/s43586-024-00330-6","article-title":"Spatial multiplexing and omics","volume":"4","author":"Carstens","year":"2024","journal-title":"Nat Rev Methods Primers"}],"container-title":["Cellular and Molecular Gastroenterology and Hepatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352345X26001451?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352345X26001451?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T21:46:24Z","timestamp":1791927984000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2352345X26001451"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026]]},"references-count":91,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2026]]}},"alternative-id":["S2352345X26001451"],"URL":"https:\/\/doi.org\/10.1016\/j.jcmgh.2026.101867","relation":{},"ISSN":["2352-345X"],"issn-type":[{"value":"2352-345X","type":"print"}],"subject":[],"published":{"date-parts":[[2026]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Mapping the Impact of Janus Kinase Inhibitors at a Cellular Resolution in Inflammatory Bowel Disease","name":"articletitle","label":"Article Title"},{"value":"Cellular and Molecular Gastroenterology and Hepatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jcmgh.2026.101867","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Inc. on behalf of American Gastroenterological Association Institute.","name":"copyright","label":"Copyright"}],"article-number":"101867"}}